Zinc oxide nanoparticle suspensions and layer-by-layer coatings inhibit staphylococcal growth

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 12, Issue 1, 2016, Pages 33-42

  McGuffie, Matthew J ^a,d,e   Hong, Jin ^f   Bahng, Joong Hwan ^c   Glynos, Emmanouil ^b,e   Green, Peter F ^b,c   Kotov, Nicholas A ^b,c,e   Younger, John G ^a,d,e   VanEpps, J Scott ^a,d,e  

^a Department of Emergency Medicine ^*  (United States)

^b University of Michigan   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^e UNIVERSITY OF MICHIGAN   (United States)

^f CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Biofilm; Layer by layer; Nanoparticles; Staphylococcus; Zinc oxide

Indexed keywords

BACTERIA; BIOFILMS; BIOMEDICAL EQUIPMENT; COATINGS; MICROORGANISMS; NANOPARTICLES; SURFACE CHEMISTRY; ZINC; ZINC COATINGS;

ANTI-MICROBIAL PROPERTIES; BACTERIAL COLONIZATION; DIFFERENTIAL SUSCEPTIBILITY; IMPLANTED MEDICAL DEVICES; LAYER BY LAYER; STAPHYLOCOCCUS; SURFACE HYDROPHOBICITY; ZINC OXIDE NANOPARTICLES;

ZINC OXIDE;

ZINC OXIDE NANOPARTICLE; ANTIINFECTIVE AGENT; BIOCOMPATIBLE COATED MATERIAL; METAL NANOPARTICLE; SUSPENSION; ZINC OXIDE;

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL STRAIN; BIOFILM; CONTROLLED STUDY; ESCHERICHIA COLI; GROWTH CURVE; GROWTH INHIBITION; HYDROPHOBICITY; KLEBSIELLA PNEUMONIAE; LEACHING; MATERIAL COATING; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PLANKTON; STAPHYLOCOCCUS EPIDERMIDIS; SURFACE AREA; SUSPENSION; ADSORPTION; BACTERIUM ADHERENCE; CELL PROLIFERATION; CHEMISTRY; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; MATERIALS TESTING; PHYSIOLOGY; STAPHYLOCOCCUS; SYNTHESIS; THREE DIMENSIONAL PRINTING;

ADSORPTION; ANTI-BACTERIAL AGENTS; BACTERIAL ADHESION; BIOFILMS; CELL PROLIFERATION; COATED MATERIALS, BIOCOMPATIBLE; MATERIALS TESTING; METAL NANOPARTICLES; PRINTING, THREE-DIMENSIONAL; STAPHYLOCOCCUS; SUSPENSIONS; ZINC OXIDE;

EID: 84957056999     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2015.10.002     Document Type: Article

References (32)

1. Darouiche R.O. Treatment of infections associated with surgical implants. N Engl J Med 2004, 350(14):1422-1429. [PubMed PMID: 15070792].
2. Maki D.G., Kluger D.M., Crnich C.J. The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin Proc 2006, 81(9):1159-1171.
3. Zhang L., Jiang Y., Ding Y., Povey M., York D. Investigation into the antibacterial behaviour of suspensions of ZnO nanoparticles (ZnO nanofluids). J Nanopart Res 2007, 9(3):479-489. [English].
4. Raghupathi K.R., Koodali R.T., Manna A.C. Size-dependent bacterial growth inhibition and mechanism of antibacterial activity of zinc oxide nanoparticles. Langmuir 2011, 27(7):4020-4028. [PubMed PMID: 21401066. Epub 2011/03/16. eng].
5. Jones N., Ray B., Ranjit K.T., Manna A.C. Antibacterial activity of ZnO nanoparticle suspensions on a broad spectrum of microorganisms. FEMS Microbiol Lett 2008, 279(1):71-76.
6. Applerot G., Perkas N., Amirian G., Girshevitz O., Gedanken A. Coating of glass with ZnO via ultrasonic irradiation and a study of its antibacterial properties. Appl Surf Sci 2009, 256(3, Supplement):S3-S8.
7. Applerot G., Lellouche J., Perkas N., Nitzan Y., Gedanken A., Banin E. ZnO nanoparticle-coated surfaces inhibit bacterial biofilm formation and increase antibiotic susceptibility. RSC Adv 2012, 2(6):2314-2321.
8. Politano A.D., Campbell K.T., Rosenberger L.H., Sawyer R.G. Use of silver in the prevention and treatment of infections: silver review. Surg Infect (Larchmt) 2013 Feb, 14(1):8-20. [PubMed PMID: 23448590. Epub 2013/03/02. eng].
9. Premanathan M., Karthikeyan K., Jeyasubramanian K., Manivannan G. Selective toxicity of ZnO nanoparticles toward Gram-positive bacteria and cancer cells by apoptosis through lipid peroxidation. Nanomedicine 2011 Apr, 7(2):184-192. [PubMed PMID: 21034861].
10. Hanley C., Layne J., Punnoose A., Reddy K.M., Coombs I., Coombs A., et al. Preferential killing of cancer cells and activated human T cells using ZnO nanoparticles. Nanotechnology 2008, 19(29):295103. [PubMed PMID: PMC2558672].
11. Reddy K.M., Feris K., Bell J., Wingett D.G., Hanley C., Punnoose A. Selective toxicity of zinc oxide nanoparticles to prokaryotic and eukaryotic systems. Appl Phys Lett 2007, 90(21):213902-1-213902-3.
12. Lai N.M., Chaiyakunapruk N., Lai N.A., O'Riordan E., Pau W.S., Saint S. Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults. Cochrane Database Syst Rev 2013, 6:CD007878. [PubMed PMID: 23740696. Epub 2013/06/07. eng].
13. Neal A.L. What can be inferred from bacterium-nanoparticle interactions about the potential consequences of environmental exposure to nanoparticles?. Ecotoxicology 2008, 17(5):362-371. [PubMed PMID: 18454313. Epub 2008/05/06. eng].
14. Halverson S., Malani P.N., Newton D.W., Habicht A., Vander Have K., Younger J.G. Impact of hourly emergency department patient volume on blood culture contamination and diagnostic yield. J Clin Microbiol 2013 Jun, 51(6):1721-1726. [PubMed PMID: 23515549. Pubmed Central PMCID: PMC3716046. Epub 2013/03/22. Eng].
15. Yang M., Sun K., Kotov N.A. Formation and assembly-disassembly processes of ZnO hexagonal pyramids driven by dipolar and excluded volume interactions. J Am Chem Soc 2010, 132(6):1860-1872.
16. Palchoudhury S., Xu Y., Rushdi A., Holler R.A., Bao Y. Controlled synthesis of iron oxide nanoplates and nanoflowers. Chem Commun 2012, 48(85):10499-10501.
17. Bellon-Fontaine M.N., Rault J., van Oss C.J. Microbial adhesion to solvents: a novel method to determine the electron-donor/electron-acceptor or Lewis acid-base properties of microbial cells. Colloids Surf B Biointerfaces 1996, 7(1-2):47-53.
18. Satorius A.E., Szafranski J., Pyne D., Ganesan M., Solomon M.J., Newton D.W., et al. Complement c5a generation by staphylococcal biofilms. Shock 2013, 39(4):336-342. [PubMed PMID: 23459111. Epub 2013/03/06. eng].
19. Orizondo R.A., Babcock C.I., Fabiilli M.L., Pavlovsky L., Fowlkes J.B., Younger J.G., et al. Characterization of a reverse-phase perfluorocarbon emulsion for the pulmonary delivery of tobramycin. J Aerosol Med Pulm Drug Deliv 2014, 27(5):392-399. [PubMed PMID: 24476046. Epub 2014/01/31. Eng].
20. Ceri H., Olson M.E., Stremick C., Read R.R., Morck D., Buret A. The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol 1999 Jun, 37(6):1771-1776. [PubMed PMID: 10325322. Pubmed Central PMCID: PMC84946. Epub 1999/05/15. eng].
21. Moussodia R.-O., Balan L., Merlin C., Mustin C., Schneider R. Biocompatible and stable ZnO quantum dots generated by functionalization with siloxane-core PAMAM dendrons. J Mater Chem 2010, 20(6):1147-1155.
22. Sawai J., Igarashi H., Hashimoto A., Kokugan T., Shimizu M. Evaluation of growth inhibitory effect of ceramics powder slurry on bacteria by conductance method. J Chem Eng Japan 1995, 28(3):288-293.
23. Sawai J., Igarashi H., Hashimoto A., Kokugan T., Shimizu M. Effect of particle size and heating temperature of ceramic powders on antibacterial activity of their slurries. J Chem Eng Japan 1996, 29(2):251-256.
24. Sawai J., Saito I., Kanou F., Igarashi H., Hashimoto A., Kokugan T., et al. Mutagenicity test of ceramic powder which have growth inhibitorory effect on bacteria. J Chem Eng Japan 1995, 28(3):352-354.
25. Brayner R., Ferrari-Iliou R., Brivois N., Djediat S., Benedetti M.F., Fiévet F. Toxicological impact studies based on Escherichia coli bacteria in ultrafine ZnO nanoparticles colloidal medium. Nano Lett 2006, 6(4):866-870.
26. Zhang L., Jiang Y., Ding Y., Daskalakis N., Jeuken L., Povey M., et al. Mechanistic investigation into antibacterial behaviour of suspensions of ZnO nanoparticles against E. coli. J Nanopart Res 2010, 12(5):1625-1636. [English].
27. Stankovic A., Dimitrijevic S., Uskokovic D. Influence of size scale and morphology on antibacterial properties of ZnO powders hydrothemally synthesized using different surface stabilizing agents. Colloids Surf B Biointerfaces 2013 Feb 1, 102:21-28. [PubMed PMID: 23010107. Epub 2012/09/27. eng].
28. Arakha M., Saleem M., Mallick B.C., Jha S. The effects of interfacial potential on antimicrobial propensity of ZnO nanoparticle. Sci Rep 2015, 5.
29. Zhang L., Ding Y., Povey M., York D. ZnO nanofluids - a potential antibacterial agent. Proc Natl Acad Sci U S A 2008, 18(8):939-944.
30. Ramani M., Ponnusamy S., Muthamizhchelvan C., Cullen J., Krishnamurthy S., Marsili E. Morphology-directed synthesis of ZnO nanostructures and their antibacterial activity. Colloids Surf B Biointerfaces 2013 May 1, 105:24-30. [PubMed PMID: 23352944. Epub 2013/01/29. eng].
31. Singh A.V., Vyas V., Patil R., Sharma V., Scopelliti P.E., Bongiorno G., et al. Quantitative characterization of the influence of the nanoscale morphology of nanostructured surfaces on bacterial adhesion and biofilm formation. PLoS One 2011, 6(9):e25029.
32. Darouiche R.O., Mansouri M.D., Gawande P.V., Madhyastha S. Antimicrobial and antibiofilm efficacy of triclosan and DispersinB combination. J Antimicrob Chemother 2009 Jul, 64(1):88-93. [PubMed PMID: 19447791].